405 related articles for article (PubMed ID: 25765789)
1. [Epigenetic dysregulation in myelodysplastic syndrome].
Sashida G; Iwama A
Rinsho Ketsueki; 2015 Feb; 56(2):111-8. PubMed ID: 25765789
[TBL] [Abstract][Full Text] [Related]
2. [Epigenetic dysregulation in myelodysplastic syndromes].
Sashida G
Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
[TBL] [Abstract][Full Text] [Related]
3. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.
Sperling AS; Gibson CJ; Ebert BL
Nat Rev Cancer; 2017 Jan; 17(1):5-19. PubMed ID: 27834397
[TBL] [Abstract][Full Text] [Related]
4. Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes.
Stankov K; Stankov S; Katanic J
Curr Pharm Des; 2017; 23(1):135-169. PubMed ID: 27697023
[TBL] [Abstract][Full Text] [Related]
5. The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.
Gonzalez-Lugo JD; Chakraborty S; Verma A; Shastri A
Semin Hematol; 2021 Jan; 58(1):56-65. PubMed ID: 33509444
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics in benzene-associated myelodysplastic syndromes and acute myeloid leukemia: new insights into a disease continuum.
Irons RD; Kerzic PJ
Ann N Y Acad Sci; 2014 Mar; 1310():84-8. PubMed ID: 24611724
[TBL] [Abstract][Full Text] [Related]
7. [Research progress on mechanism of MDS transformation into AML].
Wang LL; Gao C; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):254-9. PubMed ID: 21362264
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients.
Kim Y; Jekarl DW; Kim J; Kwon A; Choi H; Lee S; Kim YJ; Kim HJ; Kim Y; Oh IH; Kim M
Stem Cell Res; 2015 Mar; 14(2):177-84. PubMed ID: 25665922
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic alterations in myelodysplastic syndrome.
Mihara K; Takihara Y; Kimura A
Cytogenet Genome Res; 2007; 118(2-4):297-303. PubMed ID: 18000383
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
11. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic signatures as prognostic tools in acute myeloid leukemia and myelodysplastic syndromes.
Christopeit M; Bartholdy B
Epigenomics; 2014; 6(4):371-4. PubMed ID: 25333846
[No Abstract] [Full Text] [Related]
13. Epidemiology and Pathogenesis of Myelodysplastic Syndrome.
Rotter LK; Shimony S; Ling K; Chen E; Shallis RM; Zeidan AM; Stahl M
Cancer J; 2023 May-Jun 01; 29(3):111-121. PubMed ID: 37195766
[TBL] [Abstract][Full Text] [Related]
14. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia.
Karlic H; Herrmann H; Varga F; Thaler R; Reitermaier R; Spitzer S; Ghanim V; Blatt K; Sperr WR; Valent P; Pfeilstöcker M
Crit Rev Oncol Hematol; 2014 Apr; 90(1):1-16. PubMed ID: 24183913
[TBL] [Abstract][Full Text] [Related]
15. p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia.
Man N; Mas G; Karl DL; Sun J; Liu F; Yang Q; Torres-Martin M; Itonaga H; Martinez C; Chen S; Xu Y; Duffort S; Hamard PJ; Chen C; Zucconi BE; Cimmino L; Yang FC; Xu M; Cole PA; Figueroa ME; Nimer SD
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622806
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of epigenetic markers and epigenetic profiling in myeloid malignancies.
McDevitt MA
Semin Oncol; 2012 Feb; 39(1):109-22. PubMed ID: 22289497
[TBL] [Abstract][Full Text] [Related]
17. Acute Myeloid Leukemia Arising from Myelodysplastic Syndromes.
Kwon A; Weinberg OK
Clin Lab Med; 2023 Dec; 43(4):657-667. PubMed ID: 37865509
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications in AML and MDS.
Mahmud M; Stebbing J
Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
[No Abstract] [Full Text] [Related]
19. Role of DNA methylation in the pathogenesis and treatment of myelodysplastic syndromes.
Khan H; Vale C; Bhagat T; Verma A
Semin Hematol; 2013 Jan; 50(1):16-37. PubMed ID: 23507481
[TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis and therapy related MDS/AML.
Desai P; Roboz GJ
Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
